These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 13678555)

  • 41. What is the role of the D3 receptor in addiction? A mini review of PET studies with [(11)C]-(+)-PHNO.
    Payer D; Balasubramaniam G; Boileau I
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jul; 52():4-8. PubMed ID: 23999545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experimental protocols for behavioral imaging: seeing animal models of drug abuse in a new light.
    Aarons AR; Talan A; Schiffer WK
    Curr Top Behav Neurosci; 2012; 11():93-115. PubMed ID: 22411423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Imaging the addicted brain: from molecules to behavior.
    Volkow ND
    J Nucl Med; 2004 Nov; 45(11):13N-16N, 19N-20N, 22N passim. PubMed ID: 15584131
    [No Abstract]   [Full Text] [Related]  

  • 44. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.
    Volkow ND; Chang L; Wang GJ; Fowler JS; Leonido-Yee M; Franceschi D; Sedler MJ; Gatley SJ; Hitzemann R; Ding YS; Logan J; Wong C; Miller EN
    Am J Psychiatry; 2001 Mar; 158(3):377-82. PubMed ID: 11229977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Addiction.
    Lingford-Hughes AR; Davies SJ; McIver S; Williams TM; Daglish MR; Nutt DJ
    Br Med Bull; 2003; 65():209-22. PubMed ID: 12697627
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Imaging receptor changes in human drug abusers.
    Cosgrove KP
    Curr Top Behav Neurosci; 2010; 3():199-217. PubMed ID: 21161754
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radioligands for brain 5-HT2 receptor imaging in vivo: why do we need them?
    Busatto GF
    Eur J Nucl Med; 1996 Aug; 23(8):867-70. PubMed ID: 8753673
    [No Abstract]   [Full Text] [Related]  

  • 48. [Neurobiological basis of drug addiction].
    Fernández-Espejo E
    Rev Neurol; 2002 Apr 1-15; 34(7):659-64. PubMed ID: 12080517
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Imaging the roles of the amygdala in drug addiction.
    Kilts CD
    Psychopharmacol Bull; 2001; 35(1):84-94. PubMed ID: 12397873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural, functional and spectroscopic MRI studies of methamphetamine addiction.
    Salo R; Fassbender C
    Curr Top Behav Neurosci; 2012; 11():321-64. PubMed ID: 22094881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers.
    Volkow ND; Chang L; Wang GJ; Fowler JS; Franceschi D; Sedler MJ; Gatley SJ; Hitzemann R; Ding YS; Wong C; Logan J
    Am J Psychiatry; 2001 Mar; 158(3):383-9. PubMed ID: 11229978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolic correlates of toluene abuse: decline and recovery of function in adolescent animals.
    Schiffer WK; Lee DE; Alexoff DL; Ferrieri R; Brodie JD; Dewey SL
    Psychopharmacology (Berl); 2006 Jun; 186(2):159-67. PubMed ID: 16703400
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brain Volume Correlates with Duration of Abstinence from Substance Abuse in a Region-Specific and Substance-Specific Manner.
    Korponay C; Kosson DS; Decety J; Kiehl KA; Koenigs M
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2017 Oct; 2(7):626-635. PubMed ID: 29308437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings.
    Le Foll B; Collo G; Rabiner EA; Boileau I; Merlo Pich E; Sokoloff P
    Prog Brain Res; 2014; 211():255-75. PubMed ID: 24968784
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PET and SPECT in drug and substance abuse.
    Mena JC; Cuellar H; Vargas D; Riascos R
    Top Magn Reson Imaging; 2005 Jun; 16(3):253-6. PubMed ID: 16340650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Food and drug reward: overlapping circuits in human obesity and addiction.
    Volkow ND; Wang GJ; Fowler JS; Tomasi D; Baler R
    Curr Top Behav Neurosci; 2012; 11():1-24. PubMed ID: 22016109
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug dependence and addiction, III: Expectation and brain function in drug abuse.
    Volkow N
    Am J Psychiatry; 2004 Apr; 161(4):621. PubMed ID: 15056504
    [No Abstract]   [Full Text] [Related]  

  • 58. Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations.
    Villemagne V; Yuan J; Wong DF; Dannals RF; Hatzidimitriou G; Mathews WB; Ravert HT; Musachio J; McCann UD; Ricaurte GA
    J Neurosci; 1998 Jan; 18(1):419-27. PubMed ID: 9412518
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical studies in Alzheimer patients with positron emission tomography.
    Nordberg A
    Behav Brain Res; 1993 Nov; 57(2):215-24. PubMed ID: 7906947
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Positron emission tomography radioligands for dopamine transporters and studies in human and nonhuman primates.
    Volkow ND; Fowler JS; Ding YS; Wang GJ; Gatley SJ
    Adv Pharmacol; 1998; 42():211-4. PubMed ID: 9327881
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.